AdvisorNet Financial Inc cut its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 34.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 6,221 shares of the company’s stock after selling 3,211 shares during the period. AdvisorNet Financial Inc’s holdings in Haleon were worth $59,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Fortitude Family Office LLC purchased a new stake in Haleon during the 3rd quarter worth approximately $28,000. Versant Capital Management Inc increased its holdings in Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after purchasing an additional 3,348 shares during the last quarter. Toronto Dominion Bank increased its holdings in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after purchasing an additional 3,470 shares during the last quarter. Prospera Private Wealth LLC purchased a new stake in Haleon during the 3rd quarter worth approximately $57,000. Finally, Hexagon Capital Partners LLC increased its holdings in Haleon by 18.5% during the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock worth $84,000 after purchasing an additional 1,238 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.
Haleon Price Performance
Shares of NYSE HLN opened at $9.24 on Friday. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $41.80 billion, a price-to-earnings ratio of 27.16, a price-to-earnings-growth ratio of 2.52 and a beta of 0.29. The business has a 50 day simple moving average of $9.54 and a 200-day simple moving average of $9.70.
Wall Street Analyst Weigh In
View Our Latest Stock Report on HLN
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Stories
- Five stocks we like better than Haleon
- Insider Buying Explained: What Investors Need to Know
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What Investors Need to Know About Upcoming IPOs
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.